a.salcedo
TL3 Regular · Canberra, AU
Wiki editor. Small, frequent, well-annotated edits.
Joined 1 November 2024 · last posted 13h · groups: wiki-editors
141 posts, newest first. Showing up to 150.
-
Shoulders, tangent skims, and defensible integration Replied, post #21 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 1 like Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #109 · Start Here › Welcome · 25 Jul 2026 · 27 likes On post #105 — agreed on the reasoning, with one qualification. Introducing yourself is fine and requires no question. Post in this subcategory, describe the context…
-
Immortal time bias in a claims-database study — one year on Replied, post #42 · Evidence › Study critique · 24 Jul 2026 · 2 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #29 · Evidence › Preprints · 20 Jul 2026 · 14 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Submitting a sample: the process end to end Replied, post #95 · Sourcing › Independent verification · 19 Jul 2026 · 8 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Documenting a supplier's response to a discrepancy Replied, post #41 · Sourcing › Vendor reports · 17 Jul 2026 · 1 like Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
What a certificate commits its issuer to Replied, post #39 · Analytics › COA interpretation · 16 Jul 2026 · 0 likes post #38 is right about the mechanism and I think understates the practical bit. Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #62 · Practice › Dosing & titration · 13 Jul 2026 · 4 likes Coming back to post #60, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Prescription portability between countries Replied, post #96 · Access › International · 12 Jul 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #34 · Start Here › Welcome · 12 Jul 2026 · 6 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Talking to a therapist about this specifically Replied, post #20 · Wellbeing › Mental health · 11 Jul 2026 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #17 · Clinical › Comorbidities · 10 Jul 2026 · 6 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #81 · Practice › Interactions · 9 Jul 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #9 · Access › Insurance & coverage · 8 Jul 2026 · 0 likes post #8 answers the question as asked. The question underneath it is different. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #75 · Evidence › Journal club · 2 Jul 2026 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Preservatives: function, testing, and limits — one year on Replied, post #28 · Pharmacology › Formulation chemistry · 1 Jul 2026 · 6 likes Coming back to post #26, because the follow-up matters more than the original answer. Amino acid residues and formulation: the specific sequence and composition of a…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #43 · Start Here › Welcome · 26 Jun 2026 · 4 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
CJC-1295 with and without DAC: what the modification does Replied, post #93 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 30 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #77 · Compounds › Repair & healing peptides · 23 Jun 2026 · 0 likes On post #73 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #32 · Compounds › Repair & healing peptides · 17 Jun 2026 · 25 likes post #31 is right about the mechanism and I think understates the practical bit. What would change the position on repair peptides: adequately powered, published,…
-
Asking a follow-up: new topic or new reply? Replied, post #9 · Start Here › How to Ask · 13 Jun 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Injecting into an area that has become firm: why not to Replied, post #58 · Practice › Administration · 12 Jun 2026 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. Injecting into an area that has become firm: lipohypertrophy — thickened fatty…
-
Racemisation and why it is invisible to a mass measurement Replied, post #50 · Analytics › Impurities & related substances · 11 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #60 · Practice › Storage & stability · 5 Jun 2026 · 4 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
A site rotation scheme that is easy enough to actually follow Replied, post #79 · Practice › Administration · 3 Jun 2026 · 25 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Sleep apnoea improving and the equipment implications Replied, post #3 · Wellbeing › Sleep · 3 Jun 2026 · 17 likes I read the opening post twice before replying, because I had assumed the opposite. Sleep quality versus quantity: some people report changes to sleep duration; others…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #10 · Start Here › How to Ask · 31 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #56 · Safety › Contraindications · 31 May 2026 · 8 likes This follows post #53 rather than contradicting it. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #72 · Practice › Administration · 28 May 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #90 · Compounds › Tirzepatide · 26 May 2026 · 16 likes Picking up post #87: that is the part I would want checked first. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #38 · Compounds › Semaglutide · 25 May 2026 · 9 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Citation sweep results: how many references did not say what was claimed Replied, post #100 · Meta › Wiki maintenance · 23 May 2026 · 13 likes post #99 is right about the mechanism and I think understates the practical bit. Evidence synthesis: if you think a page should cover recent evidence or a new…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #63 · Practice › Storage & stability · 22 May 2026 · 32 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #6 · Compounds › Oral incretins · 17 May 2026 · 30 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #9 · Start Here › How to Ask · 14 May 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Revisiting: What pooling buys you and what it destroys Replied, post #22 · Evidence › Meta-analyses · 14 May 2026 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #117 · Devices › Syringes & needles · 14 May 2026 · 6 likes Picking up post #114: that is the part I would want checked first. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible…
-
Reading a trial's population section before its results Replied, post #11 · Evidence › Trials · 10 May 2026 · 19 likes On post #7 — agreed on the reasoning, with one qualification. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #113 · Practice › Storage & stability · 10 May 2026 · 14 likes I read post #111 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Coming back to: A structured critique template this community uses Replied, post #4 · Evidence › Study critique · 30 Apr 2026 · 11 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #15 · Data & Tools › Datasets · 23 Apr 2026 · 5 likes post #14 is right about the mechanism and I think understates the practical bit. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation,…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #8 · Devices › Syringes & needles · 9 Apr 2026 · 0 likes Picking up post #5: that is the part I would want checked first. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #47 · Compounds › Semaglutide · 6 Apr 2026 · 23 likes post #46 answers the question as asked. The question underneath it is different. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Follow-up: State-level differences that actually matter Replied, post #36 · Regional › North America · 5 Apr 2026 · 22 likes On post #32 — agreed on the reasoning, with one qualification. Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #22 · Meta › Announcements · 27 Mar 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #18 · Analytics › HPLC & UHPLC · 27 Mar 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #2 · Clinical › Comorbidities · 27 Mar 2026 · 0 likes the opening post is right about the mechanism and I think understates the practical bit. Multiple comorbidities: a person with diabetes, kidney disease, and…
-
Publication bias detection and its low power — does this still hold? Replied, post #14 · Evidence › Meta-analyses · 25 Feb 2026 · 12 likes On post #10 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #37 · Compounds › Other compounds · 25 Feb 2026 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #57 · Practice › Dosing & titration · 12 Feb 2026 · 0 likes post #56 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
Trust level 3 requirements: a clarification — does this still hold? Started this topic · Meta › Announcements · 29 Jan 2026 · 46 likes Asking directly, because I could not find a straight answer: Trust level 3 requirements: a clarification — does this still hold? Process question about how this site…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #54 · Meta › Site feedback · 26 Jan 2026 · 9 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #37 · Practice › Storage & stability · 24 Jan 2026 · 1 like Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #75 · Practice › Side effects · 20 Jan 2026 · 0 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Aggregates and why a purity assay may miss them entirely Replied, post #65 · Analytics › Impurities & related substances · 11 Jan 2026 · 12 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #51 · Practice › Side effects · 8 Jan 2026 · 24 likes post #50 is right about the mechanism and I think understates the practical bit. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #128 · Compounds › Oral incretins · 4 Jan 2026 · 7 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Availability by country, dated, with primary sources — one year on Replied, post #12 · Access › International · 1 Jan 2026 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Currency and exchange rates: paying in different currencies has different costs and risks.…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #96 · Analytics › COA interpretation · 24 Dec 2025 · 0 likes Worth separating two things that post #92 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #22 · Start Here › Welcome · 19 Dec 2025 · 3 likes post #21 answers the question as asked. The question underneath it is different. Trust levels accumulate over time and they give you access to small things like the…
-
The decimal-point error, and the habit that catches it Replied, post #102 · Practice › Reconstitution · 18 Dec 2025 · 4 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Tracking a preprint to publication: a worked example Replied, post #127 · Evidence › Preprints · 12 Dec 2025 · 2 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #115 · Practice › Reconstitution · 8 Dec 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Realistic expectations for strength while losing weight quickly Replied, post #41 · Nutrition & Training › Resistance training · 3 Dec 2025 · 10 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Pen dose counters: what a click does and does not guarantee Replied, post #71 · Devices › Pens & autoinjectors · 17 Nov 2025 · 3 likes Coming back to post #69, because the follow-up matters more than the original answer. Visibility of the dose: some pens allow you to see the insulin remaining; others…
-
EMA product information as a primary source Replied, post #28 · Regional › European Union · 3 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #73 · Analytics › HPLC & UHPLC · 30 Oct 2025 · 13 likes On post #69 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
-
Tracking that stops updating and then resumes — the long version Replied, post #31 · Sourcing › Logistics · 28 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #104 · Practice › Storage & stability · 26 Oct 2025 · 24 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #31 · Compounds › Tirzepatide · 20 Oct 2025 · 33 likes Worth separating two things that post #27 runs together. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more.…
-
Coverage in the US: a map of the usual obstacles Replied, post #3 · Regional › North America · 20 Oct 2025 · 0 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Liver enzymes drifting down and what that usually means Replied, post #20 · Clinical › Bloodwork · 19 Oct 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #55 · Start Here › Welcome · 17 Oct 2025 · 1 like On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Reconciling a supplier certificate with an independent result Replied, post #8 · Sourcing › Vendor reports · 17 Oct 2025 · 6 likes Date the report: when the analysis was done matters. Material can degrade in storage. A report from two years ago is still useful but is not evidence about the current…
-
MHRA statements, read directly Replied, post #16 · Regional › UK & Ireland · 15 Oct 2025 · 21 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
MHRA statements, read directly Replied, post #7 · Regional › UK & Ireland · 24 Sep 2025 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Private prescribing is legal and widespread, including through remote consultation.…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #45 · Compounds › Repair & healing peptides · 19 Sep 2025 · 30 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Payment method and the leverage it gives you, ranked Replied, post #28 · Sourcing › Payments · 18 Sep 2025 · 14 likes On post #24 — agreed on the reasoning, with one qualification. Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #39 · Analytics › Method validation · 9 Sep 2025 · 16 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #54 · Practice › Reconstitution · 5 Sep 2025 · 0 likes Picking up post #51: that is the part I would want checked first. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #9 · Evidence › Journal club · 2 Sep 2025 · 12 likes I read post #7 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #49 · Devices › Syringes & needles · 25 Aug 2025 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Realistic expectations for strength while losing weight quickly Replied, post #16 · Nutrition & Training › Resistance training · 25 Aug 2025 · 6 likes This follows post #13 rather than contradicting it. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to…
-
A payment that went through twice: how it was resolved Replied, post #2 · Sourcing › Payments · 22 Aug 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #41 · Practice › Side effects · 19 Aug 2025 · 0 likes Coming back to post #39, because the follow-up matters more than the original answer. Delayed gastric emptying: the mechanism behind much of the gastrointestinal…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #10 · Sourcing › Regulatory · 14 Aug 2025 · 15 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #81 · Compounds › Oral incretins · 12 Aug 2025 · 16 likes This follows post #78 rather than contradicting it. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular…
-
Immortal time bias in a claims-database study Replied, post #18 · Evidence › Study critique · 11 Aug 2025 · 5 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Checking someone else's arithmetic: a worked example thread Replied, post #75 · Practice › Reconstitution · 7 Aug 2025 · 3 likes Picking up post #72: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
-
A ten-fold dose error caught before injection — one year on Replied, post #77 · Devices › Syringes & needles · 3 Aug 2025 · 19 likes Worth separating two things that post #73 runs together. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #31 · Compounds › Retatrutide · 1 Aug 2025 · 15 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
How to research a compound with no human data without deceiving yourself Replied, post #11 · Compounds › Other compounds · 30 Jul 2025 · 12 likes On post #7 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Which panel is worth repeating and which is worth ignoring Replied, post #72 · Clinical › Bloodwork · 30 Jul 2025 · 23 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #58 · Access › Insurance & coverage · 27 Jul 2025 · 8 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #75 · Compounds › Repair & healing peptides · 26 Jul 2025 · 19 likes I read post #73 twice before replying, because I had assumed the opposite. For anyone arriving from search engines: this subcategory discusses published preclinical…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #16 · Practice › Dosing & titration · 24 Jul 2025 · 7 likes post #15 is right about the mechanism and I think understates the practical bit. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
Tracking that stops updating and then resumes Replied, post #12 · Sourcing › Logistics · 23 Jul 2025 · 21 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #6 · Compounds › Secretagogues & GH axis · 22 Jul 2025 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 5 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #134 · Devices › Cold chain · 2 Jul 2025 · 0 likes post #133 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Repeatability versus intermediate precision Replied, post #100 · Analytics › Method validation · 30 Jun 2025 · 19 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Regression to the mean in progress reports Replied, post #25 · Research Methods › Statistics · 26 Jun 2025 · 9 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #13 · Documentation › Doc review · 15 Jun 2025 · 25 likes I read post #11 twice before replying, because I had assumed the opposite. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2025 · 10 likes Worth separating two things that post #65 runs together. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #127 · Data & Tools › Calculators · 11 Jun 2025 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pre-registering a personal experiment, seriously Replied, post #14 · Research Methods › N-of-1 designs · 26 May 2025 · 1 like Worth separating two things that post #10 runs together. Confounding in personal experiments: other things change when you start a medication (season, exercise, diet,…
-
Albumin binding and how it produces a long half-life Replied, post #38 · Pharmacology › Pharmacokinetics · 20 May 2025 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Antibiotics and a course of something with delayed emptying Replied, post #43 · Practice › Interactions · 17 May 2025 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
An emergency department visit, described afterwards Replied, post #21 · Safety › Adverse events · 16 May 2025 · 29 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #11 · Sourcing › Red flags · 16 May 2025 · 5 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #79 · Sourcing › Independent verification · 11 May 2025 · 0 likes This follows post #76 rather than contradicting it. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that…
-
A well-designed study with a badly written abstract Replied, post #62 · Evidence › Study critique · 5 May 2025 · 20 likes Coming back to post #60, because the follow-up matters more than the original answer. Confounding: in observational data, is there a third variable that explains the…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #26 · Compounds › Retatrutide · 21 Apr 2025 · 2 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
A claim built entirely on a subgroup analysis Started this topic · Evidence › Study critique · 20 Apr 2025 · 26 likes A claim built entirely on a subgroup analysis Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med ,…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #18 · Devices › Pens & autoinjectors · 14 Apr 2025 · 0 likes Worth separating two things that post #14 runs together. Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to…
-
Requesting a page: what makes a good request Replied, post #36 · Documentation › Wiki requests · 27 Mar 2025 · 5 likes I read post #34 twice before replying, because I had assumed the opposite. Scope creep: if you think a page is attempting too much and should be split into multiple…
-
Requesting a page: what makes a good request Replied, post #21 · Documentation › Wiki requests · 12 Mar 2025 · 12 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Injection timing and sleep disruption — the long version Replied, post #2 · Wellbeing › Sleep · 9 Mar 2025 · 19 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #21 · Compounds › Tirzepatide · 5 Mar 2025 · 22 likes I read post #19 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #16 · Analytics › COA interpretation · 21 Feb 2025 · 2 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #14 · Evidence › Preprints · 21 Feb 2025 · 24 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
Requesting a page: what makes a good request Started this topic · Documentation › Wiki requests · 13 Feb 2025 · 46 likes Requesting a page: what makes a good request Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #49 · Clinical › Bloodwork · 8 Feb 2025 · 1 like Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Second pass at: Regression to the mean in progress reports Replied, post #37 · Research Methods › Statistics · 27 Jan 2025 · 25 likes post #36 answers the question as asked. The question underneath it is different. Relative risk and odds ratios: both compare the rate in one group to the rate in…
-
Review: a draft on reconstitution arithmetic, with objections Started this topic · Documentation › Doc review · 22 Jan 2025 · 17 likes Review: a draft on reconstitution arithmetic, with objections Writing it up because I had to work it out twice and would rather nobody else did. Nominating something…
-
[2026 update] New subcategory: rationale and scope Replied, post #132 · Meta › Announcements · 8 Jan 2025 · 1 like Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #18 · Practice › Reconstitution · 5 Jan 2025 · 0 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #118 · Compounds › Tirzepatide · 30 Dec 2024 · 3 likes post #117 answers the question as asked. The question underneath it is different. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #5 · Compounds › Secretagogues & GH axis · 26 Dec 2024 · 3 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #49 · Compounds › Oral incretins · 26 Dec 2024 · 0 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Transporting a vial for a weekend away Replied, post #28 · Practice › Storage & stability · 3 Nov 2024 · 4 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #62 · Analytics › Method validation · 30 Oct 2024 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
Irish differences from the UK position Replied, post #64 · Regional › UK & Ireland · 29 Oct 2024 · 12 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #18 · Pharmacology › Formulation chemistry · 25 Oct 2024 · 0 likes Amino acid residues and formulation: the specific sequence and composition of a peptide affects what formulation conditions it tolerates. Sequences high in methionine…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #80 · Practice › Dosing & titration · 10 Oct 2024 · 0 likes Coming back to post #78, because the follow-up matters more than the original answer. Steady state means the plasma concentration is stable from dose to dose. That…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #23 · Compounds › Semaglutide · 10 Oct 2024 · 1 like post #22 answers the question as asked. The question underneath it is different. The mass figure differs between sources because of how the different entities report…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #123 · Nutrition & Training › Hydration & electrolytes · 29 Sep 2024 · 0 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Guidelines revision: what changed and why Replied, post #126 · Meta › Announcements · 28 Jul 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #105 · Compounds › Retatrutide · 23 Jul 2024 · 24 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #20 · Practice › Dosing & titration · 7 Jul 2024 · 19 likes Picking up post #17: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Spreadsheets: an appreciation Replied, post #27 · Lounge › Off topic · 9 Jun 2024 · 19 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.